pre-dose concentrations above LLOQ: useful topics [Bioanalytics]

posted by mittyri  – Russia, 2015-08-30 21:24 (3954 d 16:29 ago) – Posting: # 15364
Views: 5,956

Dear Mitesh,

I think you can find the answer in the following topics: here, here or here

In a nutshell:
EMA BE GL states:
Reanalysis of study samples should be predefined in the study protocol (and/or SOP) before the actual start of the analysis of the samples.

EMA bioanalytical method validation GL states that:
In case of reanalysis because of positive pre-dose samples or because of a pharmacokinetic reason, the reanalysed samples should be identified and the initial value, the reason for reanalysis, the values obtained in the reanalyses, the finally accepted value and a justification for the acceptance should be provided

Hope it helps

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
184 visitors (0 registered, 184 guests [including 15 identified bots]).
Forum time: 13:53 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5